Ron holds an MD and a PhD (Neurosciences) from Stanford University and an MA from University College London. Over the course of his education, he has developed molecular therapeutics for Alzheimer's disease, discovered hormones of metabolism, and puzzled over the basis of the placebo effect. A California native, he traded the Valley for the Slopes to follow his passion for accelerating therapeutic discovery with Recursion. When he's not working, Ron enjoys taking on various projects which some might construe as questionably different from working.
Are you Recursion ready?
Join our passionate, innovative team—and help us realize our goal of 100 treatments by 2025.